• Research in Mathematical Education
• /
• v.27 no.2
• /
• pp.175-193
• /
• 2024

In K-12 education, reassessment is a common practice, providing students with opportunities to enhance their understanding through low-stakes assignments. However, reassessment is underutilized in higher education, including during the challenges posed by the COVID-19 pandemic. Our study advocates for expanding the use of reassessment in university settings to promote holistic learning and focus on what shifts of change were made by students in an initial mathematics content course as they sought to gain licensure for teaching in a birth (daycare/pre-K setting) to eighth-grade classrooms. Our study took place during COVID-19 semesters and aimed to examine how using a reassessment approach early on in a gateway course for Prospective Teachers (PTs) affected the pass rate of the course. Results showed significant differences between the PTs who engaged with the test recovery and those who did not. We propose recovery opportunities like ours provide the necessary guidance to support early degree necessary classes that are typically gatekeeping and, as another, likely cause too few students within the courses because they were able to advance into the teacher pipeline and out into the field. Future studies may consider how the reassessment could be done more before the official summative assessment of a unit or chapter to continue the shifts in teaching practices and pedagogy that are constant within the K-12 education systems at the university level.

• The Korean Journal of Applied Statistics
• /
• v.32 no.5
• /
• pp.741-752
• /
• 2019

The purpose of a Phase I Clinical Trial is to determine the maximum tolerated dose (MTD). MTD is important because it affects subsequent clinical trials; however, the existing method has a problem due to an inadequate dose allocated to patients. In this paper, an MTD estimation method is proposed to complement the problems of the existing MTD estimation method. The suggested method applies the initial acceleration step to the modified continual reassessment method. Monte Carlo Simulation Study is adapted to compare a suggested MTD estimation method with the standard design and the modified continual reassessment method.

• The Korean Journal of Applied Statistics
• /
• v.37 no.4
• /
• pp.411-444
• /
• 2024

The objective of Phase I clinical trials is to ascertain the maximum tolerated dose (MTD) that is safe for human administration. Accurately determining the MTD within an acceptable safety margin is imperative, necessitating evaluations up to sufficiently high doses. To estimate the MTD, a plethora of methods have been developed, encompassing algorithm-based, model-based, and model-assisted techniques. In this paper, a new dose exploration method based on continual reassessment method (CRM) is proposed to address for the shortcomings of existing dose exploration methods. Through a comprehensive simulation study, this method's efficacy was compared against that of existing methodologies across a variety of scenarios. The findings from this study underscore its enhanced precision and safety in estimating the MTD, alongside a reduction in the number of subjects required for testing.

• The Korean Journal of Applied Statistics
• /
• v.15 no.2
• /
• pp.323-336
• /
• 2002

In this paper we consider the modified continual reassessment method in which a cohort consists of three patients. Simulation has been a main research tool in the investigation of CRM. In this paper we propose complete enumeration as an alternative of simulation. Using new method we show that the expected toxicity rate at the MTD converges to the target toxicity rate well as the sample size increases.

• Transactions of the Korean Society of Mechanical Engineers B
• /
• v.20 no.12
• /
• pp.3926-3937
• /
• 1996

In recent years there has been increased interest in the continuum model associated with the solidification of binary mixtures. A review of the literature, however, shows that the model verification was not sufficient or only qualitative. Present work is conducted for the reassessment of continuum model on the solidification problems of binary mixtures widely used for model validation. In spite of using the same continuum model, the results do not agree well with those of Incropera and co-workers which are benchmark problems typically used for validation of binary mixture solidification. Inferring from the agreement of present results with the analytic, experimental and other model's numerical results, this discrepancy seems to be caused by numerical errors in applying continuum model developed by Incropera and co-workers, not by the model itself. Careful examination should be preceded before selecting validation problems.

• The Korean Journal of Applied Statistics
• /
• v.27 no.1
• /
• pp.13-20
• /
• 2014

Phase I Clinical Trials estimate a Maximum Tolerated Dose(MTD). In this paper, an MTD estimation method applied stopping rule is proposed for Phase I Clinical Trials. The suggested MTD estimation method is compared to the Continual Reassessment Method(CRM) method using a Monte Carlo simulation study.

• Animal cells and systems
• /
• v.7 no.3
• /
• pp.191-196
• /
• 2003

Taxonomic confusion has been presented within freshwater crayfishes of the genus Cambaroides since Starobogatov published morphological definition and revision of the group in 1995. He suggested that Cambaroides should be revised: the C. dauricus, contained three species C. dauricus, C. wladiwostokiensis, and C. koshewnikowi; the C. schrenckii with two. species C. schrenckii and C. sachalinensis. Also Straovogatov did not take into account the previous data. of crayfish distributions. In order to. clear up the confusion, the taxonomy of crayfish sampled from Mongolia, Russia, China, and North Korea was reassessed. Starovogatov's key could not lead to the correct identification. Also, detailed observations of apical robe of the male first pleopod did not support the taxonomy on the genus Cambaroides proposed by Starobogatov in 1995. However, some local variations of morphology exist in rostrum, pleuron, and telson of Asian crayfish. Future studies should be concentrated on whether there are geographical clines of morphology or if taxonomic subdivision is necessary.

• Journal of the Korean Statistical Society
• /
• v.32 no.1
• /
• pp.33-46
• /
• 2003

The continual reassessment method (CRM) provides a Bayesian estimation of the maximum tolerated dose (MTD) in phase I clinical trials. The CRM has been proposed as an alternative design of the standard design. The CRM has been modified to improve practical feasibility and, recently, the likelihood approach CRM has been proposed. In this paper we investigate the consistency and asymptotic normality of the modified likelihood approach CRM in which the maximum likelihood estimate is used instead of the posterior mean. Small-sample properties of the consistency is examined using complete enumeration. Both the asymptotic results and their small-sample properties show that the modified CRML outperforms the standard design.

• Korean Journal of Otorhinolaryngology-Head and Neck Surgery
• /
• v.61 no.12
• /
• pp.658-662
• /
• 2018

Background and Objectives The early assessment of treatment is not done for benign paroxysmal positional vertigo (BPPV) since the well-known phenomenon of fatigability after a repeated positional test can mimic successful treatment. The aim of this study is to evaluate the clinical implication of 'fatigability' after Epley maneuver and to identify the therapeutic efficacy of Epley maneuver in posterior canal BPPV (PC-BPPV). Subjects and Method This study was prospectively conducted by two dizziness clinics on 51 consecutive patients diagnosed with PC-BPPV. All patients included in the study received Epley maneuver treatment. The therapeutic results were reassessed immediately after a single trial of Epley maneuver. After 30 minutes, results were reassessed repeatedly to confirm the fatigability of diagnostic procedure immediately after treatment. If the treatment was not successful after 30 minutes, Epley maneuver was repeatedly performed until complete resolution. Results Immediately after the first maneuver, 45 of 51 (88.2%) patients had neither vertigo nor nystagmus during the positional test. All patients demonstrated complete resolution after receiving one to three Epley maneuvers on the day of diagnosis. 'Fatigability (false negative result)' was confirmed for only one case (1 of 6 patients, 16.7%), in which nystagmus was observed after 30 minutes but not identified immediately after the first Epley maneuver. Conclusion The therapeutic efficacy of Epley maneuver is very high in PC-BPPV. Considering the possibility of fatigability when reassessment is performed immediately after therapeutic maneuver, clinicians should avoid assessing the outcome immediately after treatment in patients with PC-BPPV.

• The Journal of Pediatrics of Korean Medicine
• /
• v.37 no.3
• /
• pp.35-48
• /
• 2023

Objectives We aimed to analyze changes in growth indicators before and after Korean medicine treatment in patients treated at the pediatric department of a hospital. Methods We analyzed the medical records of children and adolescents under 18 years of age who underwent growth assessment between January 1, 2017 and December 31, 2022. Results A total of 21 patients were selected for this study. After treatment, there was a significant increase in the height percentile, whereas bone age-chronological age (BA-CA) and predicted adult height (PAH) did not show significant changes. No major adverse reactions were observed during the treatment. Growth reassessment was conducted twice for 10 participants. When comparing the growth indicators between the assessment sessions, the height percentile showed an increasing trend between the initial and the first growth reassessment. However, there were no significant differences between BA-CA and PAH across the different assessment periods. Conclusions There is a need to establish evidence for the efficacy and safety of continuous Korean medicine growth treatment through the long-term observation of growth indicators in patients undergoing treatment for two or more periods, as well as observational studies on liver and renal function indicators.